Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2018 Mar 21;13(3):e0194957. doi: 10.1371/journal.pone.0194957

Correction: Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial

Jeffrey M Pernica, Andrew P Steenhoff, Margaret Mokomane, Banno Moorad, Kwana Lechiile, Marek Smieja, Loeto Mazhani, Ji Cheng, Matthew S Kelly, Mark Loeb, Ketil Stordal, David M Goldfarb
PMCID: PMC5862480  PMID: 29561910

The dose of Lactobacillus reuteri DSM 17938 appears incorrectly throughout the article as 5x108 colony-forming units (cfu) per day. The correct dose of of Lactobacillus reuteri DSM 17938 should be 1x108 cfu per day.

Reference

  • 1.Pernica JM, Steenhoff AP, Mokomane M, Moorad B, Lechiile K, Smieja M, et al. (2017) Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial. PLoS ONE 12(10): e0185177 https://doi.org/10.1371/journal.pone.0185177 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES